HCA

SEC source: 0001209191-18-037469 · doc4.xml · nonDerivative · entry 3

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,057

F1 · kind: The exercise of stock appreciation rights, withholding of shares and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-037474 · doc4.xml · derivative · entry 5

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013.

F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-037474 · doc4.xml · nonDerivative · entry 2

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,393.6171

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,498.6171 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-037474 · doc4.xml · nonDerivative · entry 1

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 120,393.6171

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,498.6171 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-037469 · doc4.xml · derivative · entry 4

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 4,437 shares

Expires 2023-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights, withholding of shares and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · derivative.exercise_date: The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.

SEC source: 0001209191-18-037469 · doc4.xml · nonDerivative · entry 2

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,807

F1 · kind: The exercise of stock appreciation rights, withholding of shares and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-037469 · doc4.xml · nonDerivative · entry 1

Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights, withholding of shares and sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-036362 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,432

F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-034692 · doc4.xml · derivative · entry 8

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,990

Underlying: Common Stock · 1,495 shares

Expires 2026-01-29

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on January 29, 2017.

SEC source: 0001209191-18-034692 · doc4.xml · derivative · entry 7

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,500

Underlying: Common Stock · 1,500 shares

Expires 2025-02-04

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 4, 2016.

SEC source: 0001209191-18-034692 · doc4.xml · derivative · entry 6

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,125 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The stock appreciation rights vest in four equal annual installments beginning on February 5, 2015.

SEC source: 0001209191-18-034692 · doc4.xml · derivative · entry 5

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 675 shares

Expires 2024-02-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: On February 5, 2014, the reporting person was granted 4,500 stock appreciation rights. The stock appreciation rights are eligible to vest in equal increments of up to 25% at the end of fiscal years 2014, 2015, 2016 and 2017 based upon the extent to which certain EBITDA performance targets have been met for the applicable fiscal year.

SEC source: 0001209191-18-034692 · doc4.xml · nonDerivative · entry 4

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,636

SEC source: 0001209191-18-034692 · doc4.xml · nonDerivative · entry 3

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,227

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-034692 · doc4.xml · nonDerivative · entry 2

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,732

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-034692 · doc4.xml · nonDerivative · entry 1

Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,232

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The exercise of stock appreciation rights reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-18-031874 · doc4.xml · derivative · entry 5

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 11,520 shares

Expires 2021-11-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Exercise Price was adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F4 · derivative.exercise_date: The option vested in three equal annual installments beginning on November 2, 2013.

F5 · derivative.underlying_shares: Shares have been adjusted to reflect a 4.505 to 1 stock split that occurred with respect to the Issuer's common stock effective March 9, 2011.

SEC source: 0001209191-18-031874 · doc4.xml · nonDerivative · entry 2

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,346.2575

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,451.2575 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-031874 · doc4.xml · nonDerivative · entry 1

Perlin Jonathan B · CIK 0001373493 · Pres-Clinical Services & CMO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 106,866.2575

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: Includes 1,451.2575 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.

SEC source: 0001209191-18-030536 · doc4.xml · nonDerivative · entry 1

Englebright Jane D. · CIK 0001632834 · SVP and Chief Nursing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,986

F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

SEC source: 0001209191-19-006595 · doc4.xml · nonDerivative · entry 4

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By JS Trust (Spouse, Trustee)

Disclosed balance after: 15,163

SEC source: 0001209191-19-006595 · doc4.xml · nonDerivative · entry 3

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2015 GRAT (Reporting Person, Trustee)

Disclosed balance after: 0

SEC source: 0001209191-19-006595 · doc4.xml · nonDerivative · entry 2

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By CS Trust (Spouse, Trustee)

Disclosed balance after: 7,582

SEC source: 0001209191-19-006595 · doc4.xml · nonDerivative · entry 1

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By 2015 GRAT (Reporting Person, Trustee)

Disclosed balance after: 1,662

SEC source: 0001209191-22-009466 · doc5.xml · nonDerivative · entry 1

WATERMAN ROBERT A · CIK 0001216856 · Former SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,862

SEC source: 0001209191-18-028169 · doc4.xml · nonDerivative · entry 2

FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,902

F3 · shares: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the 2019 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-18-028170 · doc4.xml · nonDerivative · entry 2

Frist William R · CIK 0001433377 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,958

F3 · shares: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the 2019 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc.

SEC source: 0001209191-18-028165 · doc4.xml · nonDerivative · entry 1

ROWE JOHN W · CIK 0001181744 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,978

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-18-028164 · doc4.xml · nonDerivative · entry 1

Riley Wayne Joseph · CIK 0001432895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,691

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-18-028162 · doc4.xml · nonDerivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,263

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-18-028160 · doc4.xml · nonDerivative · entry 1

MEYERS GEOFFREY G · CIK 0001197285 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,743

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-18-028159 · doc4.xml · nonDerivative · entry 1

LAMONT ANN H · CIK 0001199270 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,661

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-18-028158 · doc4.xml · nonDerivative · entry 1

HOLLIDAY CHARLES O JR · CIK 0001127289 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,094

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-18-028156 · doc4.xml · nonDerivative · entry 1

DEPARLE NANCY ANN · CIK 0001144511 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,662

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date.

SEC source: 0001209191-18-028155 · doc4.xml · nonDerivative · entry 1

Dennis Robert J · CIK 0001295441 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,704

F1 · kind: Represents common stock underlying 1,790 restricted share units which shall vest on the sooner of the date of the Issuer's 2019 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

SEC source: 0001209191-18-013654 · doc4.xml · derivative · entry 7

YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 923

Underlying: Common Stock · 922 shares

Expires 2026-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 1,845 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013654 · doc4.xml · derivative · entry 6

YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 825 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 1,649 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013654 · doc4.xml · nonDerivative · entry 4

YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,546

SEC source: 0001209191-18-013654 · doc4.xml · nonDerivative · entry 3

YUSPEH ALAN R · CIK 0001216859 · SVP & Chief Ethics Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,931

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-18-013652 · doc4.xml · derivative · entry 7

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,802

Underlying: Common Stock · 1,801 shares

Expires 2026-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 3,603 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013652 · doc4.xml · derivative · entry 6

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,487 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 2,974 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013652 · doc4.xml · nonDerivative · entry 4

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 254,856

SEC source: 0001209191-18-013652 · doc4.xml · nonDerivative · entry 3

WATERMAN ROBERT A · CIK 0001216856 · SVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 255,581

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-18-013648 · doc4.xml · derivative · entry 8

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,085

Underlying: Common Stock · 1,085 shares

Expires 2026-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 2,170 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013648 · doc4.xml · derivative · entry 7

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 970 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 1,940 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 4

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,608

SEC source: 0001209191-18-013648 · doc4.xml · nonDerivative · entry 3

Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: Restricted stock units convert into common stock on a one-for-one basis.

SEC source: 0001209191-18-013650 · doc4.xml · derivative · entry 11

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,264

Underlying: Common Stock · 1,264 shares

Expires 2026-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F5 · derivative.exercise_date: On February 25, 2016, the reporting person was granted 2,528 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013650 · doc4.xml · derivative · entry 10

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,008 shares

Expires 2025-02-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis.

F4 · derivative.exercise_date: On February 25, 2015, the reporting person was granted 2,015 restricted stock units, vesting in two equal annual installments beginning on the second anniversary of the grant date.

SEC source: 0001209191-18-013650 · doc4.xml · nonDerivative · entry 4

STEELE JOHN M · CIK 0001269276 · SVP & Chief Human Res. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,741